Health and Healthcare

Dendreon A Double Already? (DNDN)

If you read 24/WallSt.com’s "Ten Stocks That Could Double in 2008" from us, you saw that Dendreon (NASDAQ:DNDN) is on that list.  We weren’t expecting a 22% pop in shares this fast.  We’d like to take credit for that pop, although the real credit belongs to CNBC’s Mike Huckman who reported that Congressmen are probing the recent failed approval process in the FDA over the review and over conflicts of interest.

We have been looking for something like this to come up, although the day-after time period was not what we were thinking.

Dendreon regularly is screened for our weekly "10 Stocks Under $10" newsletter.  Shares are now up 25% at $7.03 on almost 20 million shares and options trading activity has gone through the roof today.

Jon C. Ogg
December 13, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.